Effect of Varying Doses of Dexamethasone on the Prolongation of the Interscalene Brachial Plexus Block

Effect of Varying Doses of Dexamethasone on the Duration of Analgesia and Motor Blockade in Interscalene Brachial Plexus Block

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/08/015203

Enrollment

Registered

2018-08-06

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system Health Condition 2: null- requiring shoulder or upper arm surgery

Interventions

Intervention1: Dexamethasone: dose-2mg and 8mg perineurally in a single shot Interscalene Brachial Plexus Block Control Intervention1: Dexamethasone: dose-0mg perineurally in a single shot Interscalen

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade I or II Patients undergoing upper arm (above elbow) and shoulder surgeries

Exclusion criteria

Exclusion criteria: Refusal for participating by the patient Patients on Steroid supplementation pre-operatively History of allergy to the study drug Failure of the block

Design outcomes

Primary

Measure	Time frame
Duration of analgesiaTimepoint: 0, 0.5, 1, 2, 4, 6, 12, 24 hours from time of Block	—

Secondary

Measure	Time frame
Duration of motor blockadeTimepoint: 0, 0.5, 1, 2, 4, 6, 12, 24 hours from time of Block	—

Countries

India

Contacts

Public ContactRudra Deshpande

Lilavati Hospital and Research Centre

drsatishkulkarni@yahoo.com9821321063

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026